ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
4.88% |
|
|
|
|
|
N/A |
0.00% |
41.52% |
10.53% |
---|
UNH |
UnitedHealth Group Incorporated |
0 |
4.58% |
|
|
|
|
|
N/A |
0.00% |
40.93% |
32.99% |
---|
ISRG |
Intuitive Surgical, Inc. |
0 |
3.92% |
|
|
|
|
|
N/A |
0.00% |
26.86% |
15.89% |
---|
PODD |
Insulet Corporation |
0 |
3.75% |
|
|
|
|
|
N/A |
0.00% |
52.85% |
7.33% |
---|
|
SECURITIES LENDING CF |
|
3.71% |
|
|
|
|
|
|
|
|
|
---|
EXAS |
Exact Sciences Corporation |
0 |
3.71% |
|
|
|
|
|
N/A |
0.00% |
46.55% |
11.01% |
---|
DHR |
Danaher Corporation |
0 |
3.60% |
|
|
|
|
|
N/A |
0.00% |
30.02% |
26.92% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
3.30% |
|
|
|
|
|
N/A |
0.00% |
40.67% |
53.12% |
---|
ARGX |
argenx SE |
0 |
2.89% |
|
|
|
|
|
N/A |
0.00% |
31.77% |
27.68% |
---|
LLY |
Eli Lilly and Company |
0 |
2.48% |
|
|
|
|
|
N/A |
0.00% |
40.95% |
42.16% |
---|
SYK |
Stryker Corporation |
0 |
2.47% |
|
|
|
|
|
N/A |
0.00% |
28.94% |
16.61% |
---|
UCB |
UCB SA |
|
2.47% |
|
|
|
|
|
|
|
|
|
---|
LEGN |
Legend Biotech Corporation |
0 |
2.40% |
|
|
|
|
|
N/A |
0.00% |
65.05% |
22.13% |
---|
LFST |
LifeStance Health Group, Inc. |
0 |
2.32% |
|
|
|
|
|
N/A |
0.00% |
50.03% |
14.33% |
---|
PEN |
Penumbra, Inc. |
0 |
2.31% |
|
|
|
|
|
N/A |
0.00% |
49.24% |
7.59% |
---|
INSP |
Inspire Medical Systems, Inc. |
0 |
2.16% |
|
|
|
|
|
N/A |
0.00% |
65.26% |
11.19% |
---|
TMO |
Thermo Fisher Scientific Inc. |
0 |
2.03% |
|
|
|
|
|
N/A |
0.00% |
33.54% |
33.14% |
---|
VEEV |
Veeva Systems Inc. |
0 |
1.93% |
|
|
|
|
|
N/A |
0.00% |
34.84% |
27.28% |
---|
MRK |
Merck & Co., Inc. |
0 |
1.86% |
|
|
|
|
|
N/A |
0.00% |
36.29% |
48.54% |
---|
RPRX |
Royalty Pharma plc |
0 |
1.86% |
|
|
|
|
|
N/A |
0.00% |
31.94% |
29.60% |
---|
PCVX |
Vaxcyte, Inc. |
0 |
1.85% |
|
|
|
|
|
N/A |
0.00% |
62.20% |
45.63% |
---|
MASI |
Masimo Corporation |
0 |
1.76% |
|
|
|
|
|
N/A |
0.00% |
34.26% |
31.55% |
---|
TECH |
Bio-Techne Corporation |
0 |
1.64% |
|
|
|
|
|
N/A |
0.00% |
40.49% |
52.71% |
---|
EW |
Edwards Lifesciences Corporation |
0 |
1.60% |
|
|
|
|
|
N/A |
0.00% |
35.21% |
6.97% |
---|
RMD |
ResMed Inc. |
0 |
1.46% |
|
|
|
|
|
N/A |
0.00% |
42.07% |
6.96% |
---|
RGEN |
Repligen Corporation |
0 |
1.42% |
|
|
|
|
|
N/A |
0.00% |
50.01% |
19.22% |
---|
GKOS |
Glaukos Corporation |
0 |
1.26% |
|
|
|
|
|
N/A |
0.00% |
63.70% |
29.07% |
---|
KROS |
Keros Therapeutics, Inc. |
0 |
1.26% |
|
|
|
|
|
N/A |
0.00% |
87.60% |
38.82% |
---|
ZLAB |
Zai Lab Limited |
0 |
1.25% |
|
|
|
|
|
N/A |
0.00% |
123.26% |
11.08% |
---|
BRKR |
Bruker Corporation |
0 |
1.24% |
|
|
|
|
|
N/A |
0.00% |
46.26% |
47.89% |
---|
JANX |
Janux Therapeutics, Inc. |
0 |
1.22% |
|
|
|
|
|
N/A |
0.00% |
81.13% |
18.74% |
---|
CNC |
Centene Corporation |
0 |
1.21% |
|
|
|
|
|
N/A |
0.00% |
33.21% |
41.88% |
---|
LONN |
LONZA GROUP AG |
|
1.18% |
|
|
|
|
|
|
|
|
|
---|
XENE |
Xenon Pharmaceuticals Inc. |
0 |
1.14% |
|
|
|
|
|
N/A |
0.00% |
55.26% |
4.58% |
---|
CYTK |
Cytokinetics, Incorporated |
0 |
1.13% |
|
|
|
|
|
N/A |
0.00% |
54.27% |
22.39% |
---|
DIM |
WisdomTree International MidCap Dividend... |
|
1.11% |
|
|
|
|
|
N/A |
0.00% |
N/A |
N/A |
---|
SRPT |
Sarepta Therapeutics, Inc. |
0 |
1.08% |
|
|
|
|
|
N/A |
0.00% |
82.04% |
56.49% |
---|
PRVA |
Privia Health Group, Inc. |
0 |
1.06% |
|
|
|
|
|
N/A |
0.00% |
95.71% |
29.95% |
---|
DXCM |
DexCom, Inc. |
0 |
0.99% |
|
|
|
|
|
N/A |
0.00% |
33.16% |
1.82% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
0.98% |
|
|
|
|
|
N/A |
0.00% |
29.42% |
23.44% |
---|
HUM |
Humana Inc. |
0 |
0.93% |
|
|
|
|
|
N/A |
0.00% |
55.23% |
38.29% |
---|
PHR |
Phreesia, Inc. |
0 |
0.91% |
|
|
|
|
|
N/A |
0.00% |
57.75% |
2.34% |
---|
DOCS |
Doximity, Inc. |
0 |
0.89% |
|
|
|
|
|
N/A |
0.00% |
80.36% |
19.91% |
---|
ASND |
Ascendis Pharma A/S |
0 |
0.88% |
|
|
|
|
|
N/A |
0.00% |
44.73% |
18.42% |
---|
WST |
West Pharmaceutical Services, Inc. |
0 |
0.85% |
|
|
|
|
|
N/A |
0.00% |
44.98% |
23.29% |
---|
TNDM |
Tandem Diabetes Care, Inc. |
0 |
0.74% |
|
|
|
|
|
N/A |
0.00% |
59.29% |
29.07% |
---|
ALGN |
Align Technology, Inc. |
0 |
0.72% |
|
|
|
|
|
N/A |
0.00% |
41.75% |
7.85% |
---|
TXG |
10x Genomics, Inc. |
0 |
0.67% |
|
|
|
|
|
N/A |
0.00% |
81.27% |
35.40% |
---|
ACLX |
Arcellx, Inc. |
0 |
0.61% |
|
|
|
|
|
N/A |
0.00% |
46.12% |
38.93% |
---|
AGL |
agilon health, inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
90.05% |
38.80% |
---|
ARWR |
Arrowhead Pharmaceuticals, Inc. |
0 |
0.47% |
|
|
|
|
|
N/A |
0.00% |
56.04% |
28.59% |
---|
GH |
Guardant Health, Inc. |
0 |
0.46% |
|
|
|
|
|
N/A |
0.00% |
66.47% |
22.25% |
---|
NTRA |
Natera, Inc. |
0 |
0.45% |
|
|
|
|
|
N/A |
0.00% |
53.42% |
16.92% |
---|
TYRA |
Tyra Biosciences, Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
199.94% |
47.48% |
---|
GPCR |
Structure Therapeutics Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
82.10% |
49.69% |
---|
MLTX |
MoonLake Immunotherapeutics |
0 |
0.40% |
|
|
|
|
|
N/A |
0.00% |
81.70% |
4.94% |
---|
CRNX |
Crinetics Pharmaceuticals, Inc. |
0 |
0.38% |
|
|
|
|
|
N/A |
0.00% |
70.01% |
15.27% |
---|
NTLA |
Intellia Therapeutics, Inc. |
0 |
0.29% |
|
|
|
|
|
N/A |
0.00% |
84.48% |
58.18% |
---|
IRTC |
iRhythm Technologies, Inc. |
0 |
0.29% |
|
|
|
|
|
N/A |
0.00% |
50.48% |
12.26% |
---|
ALXO |
ALX Oncology Holdings Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
270.19% |
37.22% |
---|